Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Latest late clinical blogs

Meet our experts at the following events

Conference

ACDM 2026

March 15 - 17, 2026 – Berlin, Germany – Booth 13
Conference

SOT Annual Meeting and ToxExpo 2026

March 22 - 25, 2026 – San Diego, CA – Booth 2024
Conference

Quantitative Systems Pharmacology Conference

April 8 - 10, 2026

All late clinical resources

Marbach DDI Workshop 2026

Certara Products - Simcyp, Drug-Drug Interactions (DDI), Modeling and Simulation - PBPK, Conference

Rare Disease Day 2026: Accelerating Rare Disease Drug Development Through Cross-Functional Innovation

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Rare and Neglected Diseases, Blog

Metatdata as Infrastructure: Designing for Reuse, Insight, and Auditability

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, On-Demand Webinar

FAQs: The ICH M15 Guideline and What It Means for Model-Informed Drug Development

Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development

Certara Products - Certara IQ, Modeling and Simulation - QSP, On-Demand Webinar

Simcyp® Simulator Version 25: Streamline Drug Development with Regulatory-Compliant PBPK

Certara Products - Simcyp, Modeling and Simulation - PBPK, On-Demand Webinar

Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis

Certara Products - Certara IQ, Modeling and Simulation - QSP, Publication

QSP in Inflammatory Bowel Disease (IBD): From Biomarkers to Clinical Endpoints, with Virtual Patients

Modeling and Simulation, Modeling and Simulation - QSP, Blog

Why Many Global Drugs Never Reach Japan

Clinical Pharmacology, Drug Development, Press Coverage

Trial Designs: Non-inferiority vs. Superiority vs. Equivalence

Clinical Pharmacology, Blog, Knowledge Base

Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach

Certara Services, Drug Development, Rare and Neglected Diseases, Therapeutic Specialties, Press Coverage

Leveraging the full potential of PBPK models to accelerate drug development

Certara Products - Simcyp, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation - PBPK, Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.